Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study.

Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study.

OBJECTIVES: To investigate delayed HIV diagnosis and late initiation of antiretroviral therapy (ART) in the Swiss HIV Cohort Study. METHODS: Two sub-populations were included: 1915 patients with HIV diagnosis from 1998 to 2007 and within 3 months of cohort registration (group A), and 1730 treatment...

Full description

Bibliographic Details
Main Authors:	Wolbers, M, Bucher, H, Furrer, H, Rickenbach, M, Cavassini, M, Weber, R, Schmid, P, Bernasconi, E, Hirschel, B, Battegay, M
Format:	Journal article
Language:	English
Published:	2008

Similar Items

Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study.
by: Glass, T, et al.
Published: (2006)

Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study.
by: Wolbers, M, et al.
Published: (2007)

CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.
by: Wolbers, M, et al.
Published: (2007)

Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study.
by: Fux, C, et al.
Published: (2007)

Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children.
by: Rudin, C, et al.
Published: (2010)

Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007.
by: Marie Ballif, et al.
Published: (2009-01-01)

Expansion of interferon-γ-secreting HIV-specific T cells during successful antiretroviral therapy
by: Gasser, O, et al.
Published: (2013)

Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study
by: Delphine Sculier, et al.
Published: (2017-07-01)

Kaposi sarcoma incidence in the Swiss HIV cohort study before and after highly active antiretroviral therapy
by: Polesel J, et al.
Published: (2009-06-01)

Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study
by: Martinetti Gladys, et al.
Published: (2011-01-01)

2010 guidelines for antiretroviral treatment of HIV from the International AIDS Society-USA Panel.
by: Bucher, H, et al.
Published: (2010)

Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.
by: Tracy R Glass, et al.
Published: (2012-01-01)

Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-Infection
by: Elzi Luigia, et al.
Published: (2011-11-01)

Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study.
by: Hasse, B, et al.
Published: (2014)

Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study.
by: Viktor von Wyl, et al.
Published: (2013-01-01)

The rate of mother-to-child transmission of antiretroviral drug-resistant HIV strains is low in the Swiss Mother and Child HIV Cohort Study
by: Francesca Compagno, et al.
Published: (2019-04-01)

Expansion of interferon-γ-secreting HIV-specific T cells during successful antiretroviral therapy.
by: Gasser, O, et al.
Published: (2013)

Factors Associated With Delayed and Late Initiation of Antiretroviral Therapy Among Patients With HIV in Beijing, China, 2010–2020
by: Yuanqi Mi, et al.
Published: (2023-06-01)

Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.
by: Wolbers, M, et al.
Published: (2010)

The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort Study
by: Bernard Surial, et al.
Published: (2021-01-01)

Risk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients.
by: Terra V Fatukasi, et al.
Published: (2017-01-01)

Factors associated with late initiation of antiretroviral therapy in Iran’s HIV/AIDS surveillance data
by: Mehdi sharafi, et al.
Published: (2024-01-01)

A sequential Cox approach for estimating the causal effect of treatment in the presence of time-dependent confounding applied to data from the Swiss HIV Cohort Study.
by: Gran, J, et al.
Published: (2010)

Clinician Perspectives on Delaying Initiation of Antiretroviral Therapy for Clinically Eligible HIV-Infected Patients
by: Linda Beer PhD, et al.
Published: (2015-05-01)

The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients.
by: Niko Beerenwinkel, et al.
Published: (2013-01-01)

EFFICACY OF ANTIRETROVIRAL THERAPY IN PATIENTS IN THE LATE STAGE HIV INFECTION
by: E.R. RAKHMANOV, et al.
Published: (2019-06-01)

How soon after HIV seroconversion is antiretroviral therapy initiated?
by: Babiker, A, et al.
Published: (1999)

Reply to “At the crossroads between early or delayed antiretroviral therapy initiation during TB/HIV coinfection”
by: Valeria Saraceni, et al.
Published: (2014-09-01)

Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis.
by: Török, M, et al.
Published: (2011)

Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)–associated tuberculous meningitis
by: Török, M, et al.
Published: (2011)

Graves’ disease associated with HIV disease and late immune reconstitution inflammatory syndrome following the initiation of antiretroviral therapy
by: S Ludgate, et al.
Published: (2021-10-01)

Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy.
by: Rohrbach, J, et al.
Published: (2010)

Late presentation to HIV care despite good access to health services: current epidemiological trends and how to do better
by: Katharine EA Darling, et al.
Published: (2016-08-01)

HIV-1 drug resistance in antiretroviral-naive individuals with HIV-1-associated tuberculous meningitis initiating antiretroviral therapy in Vietnam.
by: Thao, V, et al.
Published: (2012)

Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study.
by: Helen Kovari, et al.
Published: (2015-01-01)

Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared
by: Gilles Wandeler, et al.
Published: (2016-10-01)

Impact of HIV status on outcome of infectious complications in intravenous drug users.
by: Mertz, D, et al.
Published: (2009)

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines
by: Purificación Cid-Silva, et al.
Published: (2019-01-01)

Early versus delayed initiation of antiretroviral therapy for Indian HIV-Infected individuals with tuberculosis on antituberculosis treatment
by: Sinha Sanjeev, et al.
Published: (2012-07-01)

Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.
by: Marcel Wolbers, et al.
Published: (2010-02-01)